FDA Inspection 1145517 — Robert A. Riesenberg, M.D.

Robert A. Riesenberg, M.D. — FEI 3003215856

The FDA completed an inspection of Robert A. Riesenberg, M.D. on June 24, 2021 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 24, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Atlanta, GA (United States)

Additional Details

Clinical Investigator (CI)